Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide for Severe Sickle Cell Disease
NCT03240731Phase 2Completed
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Aug 2017
- Primary completion
- Apr 2024
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of haploidentical bone marrow transplant (Centre Hospitalier Intercommunal Creteil) in sickle cell disease (SCD), sponsored by Centre Hospitalier Intercommunal de Créteil. Started Aug 2017; status: completed.
02
Drugs
haploidentical bone marrow transplant (Centre Hospitalier Intercommunal Creteil)
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT03240731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03240731.